Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Journal of Medicinal Chemistry|December 1, 1985
Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statineJ Boger, L S Payne, D S Perlow, et al.The Biochemical Journal|February 1, 1990
The selectivity of statine-based inhibitors against various human aspartic proteinasesR A Jupp, B M Dunn, J W Jacobs, et al.Journal of Medicinal Chemistry|January 1, 1990
Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadomM G Bock, R M DiPardo, B E Evans, et al.The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
In vitro pharmacological profile of a novel structural class of oxytocin antagonistsD J Pettibone, B V Clineschmidt, E V Lis, et al.Journal of Medicinal Chemistry|December 1, 1988
Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonistsB E Evans, K E Rittle, M G Bock, et al.European Journal of Pharmacology|April 24, 1991
Bradykinin agonist activity of a novel, potent oxytocin antagonistD J Pettibone, B V Clineschmidt, E V Lis, et al.Endocrinology|July 1, 1989
A structurally unique, potent, and selective oxytocin antagonist derived from Streptomyces silvensisD J Pettibone, B V Clineschmidt, P S Anderson, et al.Biochemical and Biophysical Research Communications|October 14, 1988
HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteinsP L Darke, R F Nutt, S F Brady, et al.Journal of Medicinal Chemistry|October 1, 1986
Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubilityM G Bock, R M DiPardo, K E Rittle, et al.Journal of Medicinal Chemistry|October 16, 1992
Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural productP D Williams, M G Bock, R D Tung, et al.Pageof 5